RU93046329A - METHOD FOR STIMULATING LEUKOPOESIS - Google Patents

METHOD FOR STIMULATING LEUKOPOESIS

Info

Publication number
RU93046329A
RU93046329A RU93046329/14A RU93046329A RU93046329A RU 93046329 A RU93046329 A RU 93046329A RU 93046329/14 A RU93046329/14 A RU 93046329/14A RU 93046329 A RU93046329 A RU 93046329A RU 93046329 A RU93046329 A RU 93046329A
Authority
RU
Russia
Prior art keywords
leukopoesis
stimulating
myelodepression
oncology
essence
Prior art date
Application number
RU93046329/14A
Other languages
Russian (ru)
Other versions
RU2078581C1 (en
Inventor
И.Д. Трещалин
Д.А. Бодягин
Э.Р. Переверзева
А.Б. Сыркин
А.В. Асафов
В.В. Безюлев
Е.М. Трещалина
Original Assignee
Научно-производственное предприятие "Фармэк"
Filing date
Publication date
Application filed by Научно-производственное предприятие "Фармэк" filed Critical Научно-производственное предприятие "Фармэк"
Priority claimed from RU93046329/14A external-priority patent/RU2078581C1/en
Priority to RU93046329/14A priority Critical patent/RU2078581C1/en
Priority to AU65849/94A priority patent/AU6584994A/en
Priority to ES94913856T priority patent/ES2171450T3/en
Priority to EP94913856A priority patent/EP0712936B1/en
Priority to JP7500517A priority patent/JP2772140B2/en
Priority to PCT/RU1994/000084 priority patent/WO1994028153A2/en
Priority to AT94913856T priority patent/ATE212848T1/en
Priority to DE69429812T priority patent/DE69429812T2/en
Publication of RU93046329A publication Critical patent/RU93046329A/en
Publication of RU2078581C1 publication Critical patent/RU2078581C1/en
Application granted granted Critical

Links

Claims (1)

Изобретение относится к медицине, в частности к онкологии, и может быть использовано при миелодепрессии, вызванной цитостатической терапией. Сущность изобретения состоит в том, что осуществляют однократное подкожное введение натриевой соли ДНК, полученной из молок осетровых рыб. Способ не вызывает осложнений и одновременно стимулирует костно-мозговое кроветворение.The invention relates to medicine, in particular to oncology, and can be used for myelodepression caused by cytostatic therapy. The essence of the invention lies in the fact that they carry out a single subcutaneous injection of the sodium salt of DNA obtained from sturgeon milk. The method does not cause complications and at the same time stimulates bone marrow hematopoiesis.
RU93046329/14A 1993-05-24 1993-10-11 Method of leukopoiesis stimulation RU2078581C1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
RU93046329/14A RU2078581C1 (en) 1993-10-11 1993-10-11 Method of leukopoiesis stimulation
JP7500517A JP2772140B2 (en) 1993-05-24 1994-04-14 Low molecular weight deoxyribonucleic acid (DNA) of sturgeon fish sperm, method for extracting the DNA, and pharmaceutical preparation based on the DNA
ES94913856T ES2171450T3 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR WEIGHT DNA FROM STURION DATE, PROCEDURE FOR OBTAINING DNA AND PHARMACEUTICAL PREPARATION BASED ON THE SAME.
EP94913856A EP0712936B1 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
AU65849/94A AU6584994A (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
PCT/RU1994/000084 WO1994028153A2 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
AT94913856T ATE212848T1 (en) 1993-05-24 1994-04-14 LOW MOLECULAR DNA FROM STURGEON MILK, METHOD FOR OBTAINING DNA AND A PHARMACEUTICAL PREPARATION BASED THEREOF
DE69429812T DE69429812T2 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR DNA FROM STUNNED MILK, METHOD FOR THE DETERMINATION OF THE DNA AND A PHARMACEUTICAL PREPARATION BASED ON IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93046329/14A RU2078581C1 (en) 1993-10-11 1993-10-11 Method of leukopoiesis stimulation

Publications (2)

Publication Number Publication Date
RU93046329A true RU93046329A (en) 1997-01-27
RU2078581C1 RU2078581C1 (en) 1997-05-10

Family

ID=20147903

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93046329/14A RU2078581C1 (en) 1993-05-24 1993-10-11 Method of leukopoiesis stimulation

Country Status (1)

Country Link
RU (1) RU2078581C1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2179447C2 (en) * 1999-07-27 2002-02-20 Сакаева Дина Дамировна Method of prophylaxis and treatment of cytostatic and postradiation leukopenia
RU2200008C1 (en) * 2001-08-09 2003-03-10 Мельников Дмитрий Юрьевич Method for treating the cases of generalized tumor development processes
RU2222338C2 (en) * 2001-12-13 2004-01-27 Поздеев Николай Маркович Method for preparing biologically active substances
RU2234323C1 (en) * 2003-05-27 2004-08-20 Шурдов Михаил Аркадьевич Preparation eliciting antitumor, antitoxic and radioprotecting effect
RU2471490C1 (en) * 2012-02-02 2013-01-10 Общество с ограниченной ответственностью Научно-производственное объединение "Перспектива" Pharmaceutical composition for treating cytostatic myelosuppression

Similar Documents

Publication Publication Date Title
FI940674L (en) Method for preparing preserved human protein-containing pharmaceuticals for infusion or injection purposes
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
DE69114442D1 (en) Method and device for correcting the rhythm and stimulating the heart as a function of neuro signals.
RU94016393A (en) PEPTIDES possessing the ability to stimulate the growth of the growth hormone, method of production, pharmaceutical composition, method of treatment
DE69233136D1 (en) Ein selectin ligand
DE59101613D1 (en) Bone nail for the treatment of upper arm fractures.
DE69229975D1 (en) Pharmaceutical compositions containing an anticytokine
ATE147991T1 (en) AGENT FOR EXTRACTION OF ADVANCED GLYCOSYLATION END PRODUCTS
PL302304A1 (en) Peptides of body organs protecting action, method of obtaining them and their application in therapy
ATE202709T1 (en) COMPOSITIONS THAT CONTAIN G-CSF AND A TNF BINDING PROTEIN
DE3685484D1 (en)
FI871545A7 (en) A method for preparing a synergistic mixture for use in the treatment of cancer, comprising interleukin-2 and/or interferon-α and tumor necrosis factor.
EP0285441A3 (en) Synergistic immunostimulating composition and method
DE59004255D1 (en) MEDICAL DEVICE FOR STIMULATING TISSUE CONTRACTS.
DK325289D0 (en) STRONTIUM SALT, METHOD OF PREPARING IT, AND PHARMACEUTICAL AGENTS CONTAINING SALT
EP0588477A3 (en) Medicinal composition comprising tcf-ii
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
NO890174L (en) RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES.
IL105498A0 (en) Pharmaceutical composition containing ribonucleotide polymerase
IT1214739B (en) IMPROVEMENT IN CARDIAC STIMULATION SYSTEMS VIA PACEMAKER
RU93046328A (en) INJECTION PRODUCT FOR HEMOCORRECTION
RU93016030A (en) A MEDICINE STIMULATING THE GRANULOSITARY GROWTH OF HEMATOPHONYA IN CYTOSTATIC MYELODEPRESSIONS
RU92013625A (en) DRUGS, STIMULATING ERYTHROID GROWTH BLOOD DURING CYTOSTATIC MYELOPRESSIONS
RU92005267A (en) COMPOSITION FOR BIOLOGICAL STIMULATION AND CORRECTION OF PHENOTINE BODY